This thesis describes several clinical and molecular aspects of DCIS and provides potential progression markers that could contribute to the development of personalized treatment strategies in patients with DCIS

Ductaal carcinoma in situ, borstkanker, progressie markers, carcinogenesis
F.J. van Kemenade (Folkert) , C.H.M. van Deurzen (Carolien)
Erasmus University Rotterdam
Erasmus MC Cancer Institute

Doebar, S.C. (2020, May 20). Ductal carcinoma in situ: the journey to invasive breast cancer. Erasmus University Rotterdam. Retrieved from